217 related articles for article (PubMed ID: 31632026)
1. Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted
Li Y; Wang C; Sun Z; Xiao J; Yan X; Chen Y; Yu J; Wu Y
Int J Nanomedicine; 2019; 14():8179-8193. PubMed ID: 31632026
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge.
Zuo Z; Zou Y; Li Q; Guo Y; Zhang T; Wu J; He C; Eko FO
Sci Rep; 2021 May; 11(1):10389. PubMed ID: 34001988
[TBL] [Abstract][Full Text] [Related]
3. A recombinant multi-epitope peptide vaccine based on MOMP and CPSIT_p6 protein protects against Chlamydia psittaci lung infection.
Li Y; Zheng K; Tan Y; Wen Y; Wang C; Chen Q; Yu J; Xu M; Tan M; Wu Y
Appl Microbiol Biotechnol; 2019 Jan; 103(2):941-952. PubMed ID: 30467705
[TBL] [Abstract][Full Text] [Related]
4. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522.
Rose F; Wern JE; Gavins F; Andersen P; Follmann F; Foged C
J Control Release; 2018 Feb; 271():88-97. PubMed ID: 29217176
[TBL] [Abstract][Full Text] [Related]
5. MOMP and MIP DNA-loaded bacterial ghosts reduce the severity of lung lesions in mice after Chlamydia psittaci respiratory tract infection.
Zhou P; Wu H; Chen S; Bai Q; Chen X; Chen L; Zeng X; Liu L; Chen L
Immunobiology; 2019 Nov; 224(6):739-746. PubMed ID: 31561842
[TBL] [Abstract][Full Text] [Related]
6. Immunization with Chlamydia psittaci plasmid-encoded protein CPSIT_p7 induces partial protective immunity against chlamydia lung infection in mice.
Tan Y; Li Y; Zhang Y; Yu J; Wen Y; Wang C; Xu M; Chen Q; Lu C; Wu Y
Immunol Res; 2018 Aug; 66(4):471-479. PubMed ID: 30097797
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
Gupta NK; Tomar P; Sharma V; Dixit VK
Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
[TBL] [Abstract][Full Text] [Related]
8. Recombinant protein CPSIT_0846 induces protective immunity against Chlamydia psittaci infection in BALB/c mice.
Ran O; Liang M; Yu J; Yu M; Song Y; Yimou W
Pathog Dis; 2017 Apr; 75(3):. PubMed ID: 28204474
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted
Wern JE; Sorensen MR; Olsen AW; Andersen P; Follmann F
Front Immunol; 2017; 8():569. PubMed ID: 28567043
[TBL] [Abstract][Full Text] [Related]
10. A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.
Svindland SC; Pedersen GK; Pathirana RD; Bredholt G; Nøstbakken JK; Jul-Larsen Å; Guzmán CA; Montomoli E; Lapini G; Piccirella S; Jabbal-Gill I; Hinchcliffe M; Cox RJ
Influenza Other Respir Viruses; 2013 Nov; 7(6):1181-93. PubMed ID: 23170900
[TBL] [Abstract][Full Text] [Related]
11. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
Front Immunol; 2018; 9():934. PubMed ID: 29770135
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
Bento D; Staats HF; Gonçalves T; Borges O
Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
[TBL] [Abstract][Full Text] [Related]
13. Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin.
Cheng C; Bettahi I; Cruz-Fisher MI; Pal S; Jain P; Jia Z; Holmgren J; Harandi AM; de la Maza LM
Vaccine; 2009 Oct; 27(44):6239-46. PubMed ID: 19686693
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a tandem Chlamydia psittaci Pgp3 multiepitope peptide vaccine against a pulmonary chlamydial challenge in mice.
Wang C; Li Y; Wang S; Yan X; Xiao J; Chen Y; Zheng K; Tan Y; Yu J; Lu C; Wu Y
Microb Pathog; 2020 Oct; 147():104256. PubMed ID: 32416138
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies.
Liu H; Patil HP; de Vries-Idema J; Wilschut J; Huckriede A
PLoS One; 2013; 8(7):e69649. PubMed ID: 23936066
[TBL] [Abstract][Full Text] [Related]
16. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
[TBL] [Abstract][Full Text] [Related]
17. Induction of protection in mice against a respiratory challenge by a vaccine formulated with the Chlamydia major outer membrane protein adjuvanted with IC31®.
Cheng C; Cruz-Fisher MI; Tifrea D; Pal S; Wizel B; de la Maza LM
Vaccine; 2011 Mar; 29(13):2437-43. PubMed ID: 21276442
[TBL] [Abstract][Full Text] [Related]
18. Protective Immunity against
Wang C; Jin Y; Wang J; Zheng K; Lei A; Lu C; Wang S; Wu Y
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108176
[No Abstract] [Full Text] [Related]
19. Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.
Baz M; Samant M; Zekki H; Tribout-Jover P; Plante M; Lanteigne AM; Hamelin ME; Mallett C; Papadopoulou B; Boivin G
Clin Vaccine Immunol; 2012 Feb; 19(2):209-18. PubMed ID: 22190392
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy against Chlamydophila psittaci by oral immunization based on transgenic rice expressing MOMP in mice.
Zhang XX; Yu H; Wang XH; Li XZ; Zhu YP; Li HX; Luo SJ; Yuan ZG
Vaccine; 2013 Jan; 31(4):698-703. PubMed ID: 23196208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]